These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28283002)

  • 41. Predicted annual costs for inpatients with diabetes and foot ulcers in a developing country-a simulation of the current situation in Brazil.
    Rezende KF; Ferraz MB; Malerbi DA; Melo NH; Nunes MP; Pedrosa HC; Chacra AR
    Diabet Med; 2010 Jan; 27(1):109-12. PubMed ID: 20121897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation.
    Apelqvist J; Ragnarson-Tennvall G; Persson U; Larsson J
    J Intern Med; 1994 May; 235(5):463-71. PubMed ID: 8182403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Costs of Patients Admitted for Diabetic Foot Problems.
    Tan JH; Hong CC; Shen L; Tay EY; Lee JK; Nather A
    Ann Acad Med Singap; 2015 Dec; 44(12):567-70. PubMed ID: 27090076
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost-effectiveness of prevention and management of diabetic foot ulcer and amputation in a health resource-limited setting.
    Wu B; Wan X; Ma J
    J Diabetes; 2018 Apr; 10(4):320-327. PubMed ID: 28976723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A model to analyse costs and benefit of intensified diabetic foot care in Austria.
    Habacher W; Rakovac I; Görzer E; Haas W; Gfrerer RJ; Wach P; Pieber TR
    J Eval Clin Pract; 2007 Dec; 13(6):906-12. PubMed ID: 18070261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs.
    Hicks CW; Selvarajah S; Mathioudakis N; Sherman RE; Hines KF; Black JH; Abularrage CJ
    Ann Vasc Surg; 2016 May; 33():149-58. PubMed ID: 26907372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcomes and cost minimisation associated with outpatient parenteral antimicrobial therapy (OPAT) for foot infections in people with diabetes.
    Malone M; West D; Xuan W; Lau NS; Maley M; Dickson HG
    Diabetes Metab Res Rev; 2015 Sep; 31(6):638-45. PubMed ID: 25850572
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost comparison: limb salvage versus amputation in diabetic patients with charcot foot.
    Gil J; Schiff AP; Pinzur MS
    Foot Ankle Int; 2013 Aug; 34(8):1097-9. PubMed ID: 23493775
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic burden of illness associated with diabetic foot ulcers in Canada.
    Hopkins RB; Burke N; Harlock J; Jegathisawaran J; Goeree R
    BMC Health Serv Res; 2015 Jan; 15():13. PubMed ID: 25608648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effective management of diabetic foot ulcers. A review.
    Ragnarson-Tennvall G; Apelqvist J
    Pharmacoeconomics; 1997 Jul; 12(1):42-53. PubMed ID: 10173073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is diabetic foot care efficacious or cost effective?
    Armstrong DG
    Ostomy Wound Manage; 2001 Apr; 47(4):28-32. PubMed ID: 11890086
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Towards less amputations in diabetic patients. Incidence, causes, cost, treatment, and prevention--a review.
    Larsson J; Apelqvist J
    Acta Orthop Scand; 1995 Apr; 66(2):181-92. PubMed ID: 7740955
    [No Abstract]   [Full Text] [Related]  

  • 53. A Population-Based Analysis of Diabetes-Related Care Measures, Foot Complications, and Amputation During the COVID-19 Pandemic in Ontario, Canada.
    de Mestral C; Gomez D; Wilton AS; Lee DS; Albalawi Z; Austin PC; Jacob-Brassard J; Urbach DR; Al-Omran M; Baxter NN
    JAMA Netw Open; 2022 Jan; 5(1):e2142354. PubMed ID: 34985514
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Epidemiology of diabetic foot].
    Leone S; Pascale R; Vitale M; Esposito S
    Infez Med; 2012; 20 Suppl 1():8-13. PubMed ID: 22982692
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [An update on diabetic foot].
    Seguel G
    Rev Med Chil; 2013 Nov; 141(11):1464-9. PubMed ID: 24718474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diabetes-related foot disease in Australia: a systematic review of the prevalence and incidence of risk factors, disease and amputation in Australian populations.
    Zhang Y; van Netten JJ; Baba M; Cheng Q; Pacella R; McPhail SM; Cramb S; Lazzarini PA
    J Foot Ankle Res; 2021 Jan; 14(1):8. PubMed ID: 33468226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The diabetic foot in Dutch hospitals: epidemiological features and clinical outcome.
    Bouter KP; Storm AJ; de Groot RR; Uitslager R; Erkelens DW; Diepersloot RJ
    Eur J Med; 1993 Apr; 2(4):215-8. PubMed ID: 8261073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of diabetes-related foot ulcers and amputations: a cost-utility analysis based on Markov model simulations.
    Ragnarson Tennvall G; Apelqvist J
    Diabetologia; 2001 Nov; 44(11):2077-87. PubMed ID: 11719840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-hospital costs of diabetic foot disease treated by a multidisciplinary foot team.
    Rinkel WD; Luiten J; van Dongen J; Kuppens B; Van Neck JW; Polinder S; Castro Cabezas M; Coert JH
    Diabetes Res Clin Pract; 2017 Oct; 132():68-78. PubMed ID: 28802698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Health costs associated with the diabetic foot in developed countries.A plea for the creation of health care networks].
    Carpentier B; Pradines S; Benhamou PY; Halimi S
    Diabetes Metab; 2000 Feb; 26(1):75-80. PubMed ID: 10705108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.